ARTICLE | Company News
Celtrix, Genentech deal
March 22, 1993 8:00 AM UTC
CTRX received nonexclusive rights for ophthalmological uses and exclusive rights for local dermal wound healing plus nonexclusive rights for the systemic treatment of autoimmune diseases, osteoporosis...